DEC 18, 2019 1:26 PM PST

Looking to this tropical plant for future pancreatic cancer treatments

Pancreatic cancer is a dangerous disease for two reasons: its stealth and its resistance to many anti-cancer drugs. The American Cancer Society estimates that around 55,440 people receive a diagnosis of pancreatic cancer annually, representing 3% of all cancers in the United States. Because it presents few symptoms, many people don’t receive a diagnosis until the disease has already reached advanced stages, when treatment options are limited. However, new research published in the journal ChemMedChem details a treatment option that may be on the horizon for patients with pancreatic cancer – and it comes from a topical plant.

Could this plant hold the secret to new pancreatic cancer treatments?

The plant is called Uvaria grandiflora and it grows in Malaysia, Indonesia, Thailand and the Philippines. This beautiful plant contains a chemical called Grandifloracin, which, as the authors of the study explain, “is a potent anti‐austerity agent, able to suppress the ability of various pancreatic cancer cell lines to tolerate conditions of nutrient deprivation.”

What is an anti-austerity agent? Let’s unwrap that.

The researchers behind the study explain, "Pancreatic cancers are especially aggressive and fast-growing, so the tumors develop faster than the blood vessels can supply nutrients to them. This leads to a lack of nutrients, to an extent that would kill ordinary cells, but the pancreatic cancer cells can survive these 'austere' conditions and keep on growing,” elaborates Dr. Simon Lewis, Senior Lecturer in Chemistry from the University of Bath.

This study was conducted by researchers from the University of Bath in collaboration with Professor Suresh Awale from the University of Toyama, Japan who developed three molecules to mimic the natural anti-austerity properties of Grandifloracin.

"The molecules we have identified are so-called 'anti-austerity' agents that can remove the ability of the cancer cells to tolerate these starvation conditions, so they will die, whereas ordinary cells with a normal supply of nutrients remain unaffected, continues Dr. Lewis.

Of the three molecules they made, all three are capable of destroying pancreatic cancer cells in a petri dish, and two of them are even more effective than the natural properties of Grandifloracin.

Of course, looking to nature for medicinal remedies is nothing new, as Dr. Lorenzo Caggiano, Senior Lecturer in the Medicinal Chemistry group at the University's Department of Pharmacy & Pharmacology, commented: "Through evolution, nature has developed a huge variety of active compounds to help it survive and thrive under a wide range of environmental conditions. These so-called natural products are of great interest in the development of new drugs and as such approximately a quarter of all medicines are derived from plants.”

The researchers say that they hope to continue investigating the potential of these molecules for future pancreatic cancer treatments, stating that human trials for new drugs could be seen within the next five years.

Sources: Science DailyChemMedChem

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 14, 2020
Cancer
MiR-107 and Its Role in Radiosensitivity in Prostate Cancer
SEP 14, 2020
MiR-107 and Its Role in Radiosensitivity in Prostate Cancer
It is often unknown whether a patient will respond to a treatment until it is in full swing. New research is attempting ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
NOV 02, 2020
Immunology
New Cancer Drug Reboots Stalled Immunotherapies
NOV 02, 2020
New Cancer Drug Reboots Stalled Immunotherapies
In contrast to traditional chemotherapies, immunotherapies reprogram the patient’s own immune system to fight tumo ...
NOV 02, 2020
Cancer
Age impacts response to melanoma treatment
NOV 02, 2020
Age impacts response to melanoma treatment
Research from the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Bloomberg School of Public Health& ...
NOV 15, 2020
Genetics & Genomics
Novel Cancer-Driving Genes are Discovered
NOV 15, 2020
Novel Cancer-Driving Genes are Discovered
Cells have to be able to divide so new ones can replenish cells that get worn out, dysfunctional, or that accumulate dam ...
Loading Comments...